| Name | Title | Contact Details |
|---|
Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir`s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug currently in a Phase 1/2 clinical trial for hematologic and solid tumors.
We dont just treat cancer, we treat people. You can count on us to put you first and provide the most advanced treatments. Lets beat this together.
HealthChem Contract Services is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Apicore, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Venture Technology Group is a Farmington Hills, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.